Captrust Financial Advisors Pacific Biosciences Of California, Inc. Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $4,393 - $7,624	736 Added 5.72%	13,603 $133,000
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $10,501 - $17,774	1,276 Added 11.01%	12,867 $107,000
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $115,562 - $162,853	11,591 New	11,591 $154,000
Q2 2022 Aug 23, 2022	SELL	$4.02 - $10.43 $18,532 - $48,082	-4,610 Reduced 74.8%	1,553 $7,000
Q2 2022 Aug 16, 2022	BUY	$4.02 - $10.43 $16,964 - $44,014	4,220 Added 217.19%	6,163 $27,000
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $7,747 - $19,207	919 Added 89.75%	1,943 $18,000
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $27,503 - $42,954	-1,428 Reduced 58.24%	1,024 $21,000
Q3 2021 Nov 16, 2021	BUY	$24.86 - $35.02 $3,579 - $5,042	144 Added 6.24%	2,452 $63,000
Q2 2021 Aug 16, 2021	SELL	$22.3 - $36.02 $7,292 - $11,778	-327 Reduced 12.41%	2,308 $81,000
Q1 2021 May 17, 2021	BUY	$26.38 - $51.15 $69,511 - $134,780	2,635 New	2,635 $88,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.